prediction
4Q26 revenue is forecast at 1,130억원 (+14.3%) and operating profit at 137억원 (+32.2%, OPM 12.1%), with margin expected to fall versus 3Q on year-end costs and pre-investment in 헬스케어 new products and overseas expansion.
A prediction by 4Q26 전망. Statements are as reported by the cited publishers — not verified by DecisionGateway.
4Q26 매출액 1,130억원(+14.3%), 영업이익 137억원(+32.2%, OPM 12.1%) 전망.